Last reviewed · How we verify

NCT04787146: ADOPAC

File Analysis of Falling Patients: Are Drugs Frequently Involved

Completed Last updated 8 March 2021
What this trial tests

trial testing No intervention in Fall Patients in 52 participants. Completed in 28 February 2021.

Timeline
18 April 2019
Primary endpoint
15 October 2019
28 February 2021

Quick facts

Lead sponsorFondation Hôpital Saint-Joseph
StatusCompleted
Study typeOBSERVATIONAL
Enrollment52
Start date18 April 2019
Primary completion15 October 2019
Estimated completion28 February 2021
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Fondation Hôpital Saint-Joseph — full company profile →

Who can join

18 and older, any sex, with Fall Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The damage caused by patient falls is a major public health problem, due to the large and growing number of people concerned, the potentially serious consequences but also the financial cost generated by their care. These consequences can be physical as well as psychological. Fractures and pain are the first consequences that come to mind, but many others should be mentioned: post-fall syndrome, loss of autonomy or even entering an institution, fear of falling, loss of confidence in itself.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Fall Patients

Currently open trials in the same condition.

Other Fondation Hôpital Saint-Joseph trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04787146.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing